Disease | liver disease |
Phenotype | C0022661|chronic renal failure |
Sentences | 3 |
PubMedID- 20529577 | Conclusions: slkt is an effective therapy for end-stage liver disease with chronic renal failure or severe damage to renal function. |
PubMedID- 25854911 | Usefulness of liver test and controlled attenuation parameter in detection of nonalcoholic fatty liver disease in patients with chronic renal failure and coronary heart disease. |
PubMedID- 21406648 | Design, setting, and participants: cross-sectional analysis of the mean number of 9 serious chronic conditions (cancer, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, peripheral artery disease, severe liver disease, diabetes with end-organ disease, chronic renal failure, and dementia) diagnosed in 306 hospital referral regions (hrrs) in the united states; hrrs were divided into quintiles of diagnosis frequency. |
Page: 1